A mechanistic link between oxidative stress and membrane mediated amyloidogenesis revealed by infrared spectroscopy

Biochimica et Biophysica Acta - Biomembranes

Volumn 1768, Issue 8, 2007, Pages 1913-1922

  Komatsu, Hiroaki ^a   Liu, Liu ^a   Murray, Ian V J ^a   Axelsen, Paul H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42];

ALZHEIMER DISEASE; AMYLOIDOSIS; BETA SHEET; HUMAN; INFRARED SPECTROSCOPY; LIPID MEMBRANE; OXIDATIVE STRESS; PATHOGENESIS; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; REVIEW;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; CELL MEMBRANE; HUMANS; LIPIDS; OXIDATIVE STRESS; PROTEIN STRUCTURE, SECONDARY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 34547149259     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2007.05.026     Document Type: Review

References (97)

1. Shen C.L., and Murphy R.M. Solvent effects on self-assembly of beta-amyloid peptide. Biophys. J. 69 (1995) 640-651
2. Markesbery W.R. The role of oxidative stress in Alzheimer disease. Arch. Neurol. 56 (1999) 1449-1452
3. Pratico D., and Delanty N. Oxidative injury in diseases of the central nervous system: focus on Alzheimer's disease. Am. J. Med. 109 (2000) 577-585
4. Varadarajan S., Yatin S., Aksenova M., and Butterfield D.A. Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. J. Struct. Biol. 130 (2000) 184-208
5. Nunomura A., Perry G., Aliev G., Hirai K., Takeda A., Balraj E.K., Jones P.K., Ghanbari H., Wataya T., Shimohama S., Chiba S., Atwood C.S., Petersen R.B., and Smith M.A. Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 60 (2001) 759-767
6. Arlt S., Beisiegel U., and Kontush A. Lipid peroxidation in neurodegeneration: new insights into Alzheimer's disease. Curr. Opin. Lipidol. 13 (2002) 289-294
7. Butterfield D.A. Amyloid beta-peptide [1-42]-associated free radical-induced oxidative stress and neurodegeneration in Alzheimer's disease brain: mechanisms and consequences. Curr. Med. Chem. 10 (2003) 2651-2659
8. Bayer T.A., Schafer S., Breyhan H., Wirths O., Treiber C., and Multhaup G. A vicious circle: role of oxidative stress, intraneuronal A beta and Cu in Alzheimer's disease. Clin. Neuropathol. 25 (2006) 163-171
9. Terzi E., Holzemann G., and Seelig J. Self-association of beta-amyloid peptide (1-40) in solution and binding to lipid membranes. J. Mol. Biol. 252 (1995) 633-642
10. Yanagisawa K., Odaka A., Suzuki N., and Ihara Y. GM1 ganglioside-bound amyloid beta-protein (A beta): a possible form of preamyloid in Alzheimer's disease. Nat. Med. 1 (1995) 1062-1066
11. Terzi E., Holzemann G., and Seelig J. Interaction of Alzheimer beta-amyloid peptide(1-40) with lipid membranes. Biochemistry 36 (1997) 14845-14852
12. McLaurin J., and Chakrabartty A. Characterization of the interactions of Alzheimer beta-amyloid peptides with phospholipid membranes. Eur. J. Biochem. 245 (1997) 355-363
13. Choo-Smith L.-P., Garzon-Rodriguez W., Glabe C.G., and Surewicz W.K. Acceleration of amyloid fibril formation by specific binding of Abeta-(1-40) peptide to ganglioside-containing membrane vesicles. J. Biol. Chem. 272 (1997) 22987-22990
14. Choo-Smith L.-P., and Surewicz W.K. The interaction between Alzheimer amyloid beta(1-40) peptide and ganglioside GM1-containing membranes. FEBS Lett. 402 (1997) 95-98
15. McLaurin J., Franklin T., Fraser P.E., and Chakrabartty A. Structural transitions associated with the interaction of Alzheimer beta-amyloid peptides with gangliosides. J. Biol. Chem. 273 (1998) 4506-4515
16. White D.A. The Phospholipid Composition of Mammalian Tissue (1973), Elsevier, New York
17. Jeandel C., Nicolas M.B., Dubois F., Nabet-Belleville F., Penin F., and Cuny G. Lipid peroxidation and free radical scavengers in Alzheimer's disease. Gerontology 35 (1989) 275-282
18. Zhang Q.H., Powers E.T., Nieva J., Huff M.E., Dendle M.A., Bieschke J., Glabe C.G., Eschenmoser A., Wentworth P., Lerner R.A., and Kelly J.W. Metabolite-initiated protein misfolding may trigger Alzheimer's disease. Proc. Natl. Acad. Sci. U. S A. 101 (2004) 4752-4757
19. Bieschke J., Zhang Q., Powers E.T., Lerner R.A., and Kelly J.W. Oxidative metabolites accelerate Alzheimer's amyloidogenesis by a two-step mechanism, eliminating the requirement for nucleation. Biochemistry 44 (2005) 4977-4983
20. Marsh D. Dichroic ratios in polarized Fourier transform infrared for nonaxial symmetry of beta-sheet structures. Biophys. J. 72 (1997) 2710-2718
21. Axelsen P.H., Kaufman B.K., McElhaney R.N., and Lewis R.N.A.H. The infrared dichroism of transmembrane helical polypeptides. Biophys. J. 69 (1995) 2770-2781
22. Axelsen P.H., Braddock W.D., Brockman H.L., Jones C.M., Dluhy R.A., Kaufman B.K., and Puga Jr. F.J. Use of internal reflectance infrared spectroscopy for the in-situ study of supported lipid monolayers. Appl. Spectrosc. 49 (1995) 526-531
23. Blodgett K.B. Monomolecular films of fatty acids on glass. J. Am. Chem. Soc. 56 (1934) 495
24. Blodgett K.B. Films built by depositing successive monomolecular layers on a solid surface. J. Am. Chem. Soc. 57 (1935) 1007-1022
25. Rana F.R., Widayati S., Gregory B.W., and Dluhy R.A. Metasability in monolayer films transferred onto solid substrates by the Langmuir-Blodgett method: IR evidence for the transfer-induced phase transitions. Appl. Spectrosc. 48 (1994) 1196-1203
26. Langmuir I., and Schaefer V.J. Activities of urease and pepsin monolayers. J. Am. Chem. Soc. 60 (1938) 1351-1360
27. Silvestro L., and Axelsen P.H. FTIR linked analysis of conformational changes in Annexin V upon membrane binding. Biochemistry 38 (1999) 113-121
28. Kalb E., Frey S., and Tamm L.K. Formation of supported planar bilayers by fusion of vesicles to supported phospholipid monolayers. Biochim. Biophys. Acta 1103 (1992) 307-316
29. Silvestro L., and Axelsen P.H. Infrared spectroscopy of supported lipid monolayer, bilayer, and multibilayer membranes. Chem. Phys. Lipids 96 (1998) 69-80
30. Momsen W.E., Smaby J.M., and Brockman H.L. The suitability of nichrome for measurement of gas-liquid interfacial tension by the Wilhelmy method. J. Colloid Interface Sci. 135 (1990) 547-552
31. Axelsen P.H., Bajzer Z., Prendergast F.G., Cottam P.F., and Ho C. Resolution of fluorescence intensity decays of the two tryptophan residues in glutamine-binding protein of E. coli using single tryptophan mutants. Biophys. J. 60 (1991) 650-659
32. Press W.H., Flannery B.P., Teukolsky S.A., and Vetterling W.T. Numerical Recipes (1986), Cambridge Univ. Press, Cambrige
33. Kauppinen J.K., Moffatt D.J., Hollberg M.R., and Mantsch H.H. A new line-narrowing procedure based on Fourier self-deconvolution, maximum entropy, and linear prediction. Appl. Spectrosc. 45 (1991) 411-416
34. Harrick N.J. Internal Reflection Spectroscopy (1967), Harrick Scientific Corporation, Ossining, NY
35. Mirabella F.J., and Harrick N.J. Internal Reflection Spectroscopy: Review and Supplement (1985), N.J. Harrick, Harrick Scientific Corporation, Ossining, N.Y.
36. Mirabella F.J. Internal Reflection Spectroscopy: Theory and Applications, F.J. Mirabella (1993), Dekker, New York
37. Axelsen P.H., and Citra M.J. Orientational order determination by internal reflection infrared spectroscopy. Prog. Biophys. Mol. Biol. 66 (1996) 227-253
38. Citra M.J., and Axelsen P.H. Determination of molecular order in supported lipid membranes by internal reflection Fourier transform infrared spectroscopy. Biophys. J. 71 (1996) 1796-1805
39. Koppaka V., and Axelsen P.H. Evanescent electric field amplitudes in thin lipid films for internal reflection infrared spectroscopy. Langmuir 17 (2001) 6309-6316
40. Eanes E.D., and Glenner G.G. X-ray diffraction studies on amyloid filaments. J. Histochem. Cytochem. 16 (1968) 673-677
41. Kirschner D.A., Abraham C., and Selkoe D.J. X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer's disease indicates cross-beta conformation. Proc. Natl. Acad. Sci. U. S. A. 83 (1986) 503-507
42. Hilbich C., Kisterwoike B., Reed J., Masters C.L., and Beyreuther K. Aggregation and secondary structure of synthetic amyloid beta-A4 peptides Of Alzheimer's-disease. J. Mol. Biol. 218 (1991) 149-163
43. Fabian H., Choo L., Szendrei G.I., Jackson M., Halliday W.C., Otvos Jr. L., and Mantsch H.H. Infrared spectroscopic characterization of Alzheimer plaques. Appl. Spectrosc. 47 (1993) 1513-1518
44. Krimm S., and Abe Y. Intermolecular interaction effects in the Amide I vibrations of β polypeptides. Proc. Natl. Acad. Sci. U. S. A. 69 (1972) 2788-2792
45. Chirgadze Y.N., and Nevskaya N.A. Infrared spectra and resonance interaction of Amide-I vibration of the antiparallel-chain pleated sheet. Biopolymers 15 (1976) 607-625
46. Surewicz W.K., and Mantsch H.H. The conformation of dynorphin A-(1-13) in aqueous solution as studied by Fourier transform infrared spectroscopy. J. Mol. Struct. 214 (1989) 143-147
47. Halverson K.J., Sucholeiki I., Ashburn T.T., and Lansbury P.T. Location of β-Sheet-forming sequences in amyloid proteins by FTIR. J. Am. Chem. Soc. 113 (1991) 6701-6703
48. Lansbury P.T., Costa P.R., Griffiths J.M., Simon E.J., Auger M., Halverson K.J., Kocisko D.A., Hendsch Z.S., Ashburn T.T., Spencer R.G.S., Tidor B., and Griffin R.G. Structural model for the beta-amyloid fibril based on interstrand alignment of an antiparallel-sheet comprising a C-terminal peptide. Nat. Struct. Biol. 2 (1995) 990-998
49. Balbach J.J., Ishii Y., Antzutkin O.N., Leapman R.D., Rizzo N.W., Dyda F., Reed J., and Tycko R. Amyloid fibril formation by A beta(16-22), a seven-residue fragment of the Alzheimer's beta-amyloid peptide, and structural characterization by solid state NMR. Biochemistry 39 (2000) 13748-13759
50. Petkova A.T., Buntkowsky G., Dyda F., Leapman R.D., Yau W.-M., and Tycko R. Solid state NMR reveals a pH-dependent antiparallel β-Sheet registry in fibrils formed by a β-amyloid peptide. J. Mol. Biol. 335 (2004) 247-260
51. Benzinger T.L.S., Gregory D.M., Burkoth T.S., Miller-Auer H., Lynn D.G., Botto R.E., and Meredith S.C. Propagating structure of Alzheimer's beta-amyloid(10-35) is parallel beta-sheet with residues in exact register. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 13407-13412
52. Antzutkin O.N., Balbach J.J., Leapman R.D., Rizzo N.W., Reed J., and Tycko R. Multiple quantum solid-state NMR indicates a parallel, not antiparallel, organization of beta-sheets in Alzheimer's beta-amyloid fibrils. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 13045-13050
53. Balbach J.J., Petkova A.T., Oyler N.A., Antzutkin O.N., Gordon D.J., Meredith S.C., and Tycko R. Supramolecular structure in full-length Alzheimer's beta-amyloid fibrils: evidence for a parallel beta-sheet organization from solid-state nuclear magnetic resonance. Biophys. J. 83 (2002) 1205-1216
54. Torok M., Milton S., Kayed R., Wu P., McIntire T., Glabe C.G., and Langen R. Structural and dynamic features of Alzheimer's A beta peptide in amyloid fibrils studied by site-directed spin labeling. J. Biol. Chem. 277 (2002) 40810-40815
55. Silva R.A.G.D., Kubelka J., Bour P., Decatur S.M., and Keiderling T.A. Site-specific conformational determination in thermal unfolding studies of helical peptides using vibrational circular dichroism with isotopic substitution. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 8318-8323
56. Brauner J.W., Dugan C., and Mendelsohn R. C-13 isotope labeling of hydrophobic peptides. Origin of the anomalous intensity distribution in the infrared amide I spectral region of beta-sheet structures. J. Am. Chem. Soc. 112 (2000) 677-683
57. Kubelka J., and Keiderling T.A. The anomalous infrared amide I intensity distribution in C-13 isotopically labeled peptide beta-sheets comes from extended, multiple-stranded structures. An ab initio study. J. Am. Chem. Soc. 123 (2001) 6142-6150
58. Kubelka J., and Keiderling T.A. Differentiation of beta-sheet-forming structures: Ab initio-based simulations of IR absorption and vibrational CD for model peptide and protein beta-sheets. J. Am. Chem. Soc. 123 (2001) 12048-12058
59. Decatur S.M. Elucidation of residue-level structure and dynamics of polypeptides via isotope-edited infrared spectroscopy. Acc. Chem. Res. 39 (2006) 169-175
60. Paul C., Wang J.P., Wimley W.C., Hochstrasser R.M., and Axelsen P.H. Vibrational coupling, isotopic editing, and beta-sheet structure in a membrane-bound polypeptide. J. Am. Chem. Soc. 126 (2004) 5843-5850
61. Paul C., and Axelsen P.H. β sheet structure in amyloid β fibrils and vibrational dipolar coupling. J. Am. Chem. Soc. 127 (2005) 5754-5755
62. Antzutkin O.N., Leapman R.D., Balbach J.J., and Tycko R. Supramolecular structural constraints on Alzheimer's beta-amyloid fibrils from electron microscopy and solid-state nuclear magnetic resonance. Biochemistry 41 (2002) 15436-15450
63. Koppaka V., and Axelsen P.H. Accelerated accumulation of amyloid beta proteins on oxidatively damaged lipid membranes. Biochemistry 39 (2000) 10011-10016
64. Weinstein E.A., Li H.W., Lawson J.A., Rokach J., FitzGerald G.A., and Axelsen P.H. Prothrombinase acceleration by oxidatively damaged phospholipids. J. Biol. Chem. 275 (2000) 22925-22930
65. Murray I.V.J., Sindoni M.E., and Axelsen P.H. Promotion of oxidative lipid membrane damage by amyloid beta proteins. Biochemistry 44 (2005) 12606-12613
66. de Jongh H.H., Goormaghtigh E., and Ruysschaert J.M. The different molar absorptivities of the secondary structure types in the amide I region: an attenuated total reflection infrared study on globular proteins. Anal. Biochem. 242 (1996) 95-103
67. Miller D.L., Papayannopoulos I.A., Styles J., Bobin S.A., Lin Y.Y., Biemann K., and Iqbal K. Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. Arch. Biochem. Biophys. 301 (1993) 41-52
68. Selkoe D.J. Alzheimer's amyloid of another flavour. Nat. Med. 1 (1995) 998-999
69. Iwatsubo T., Saido T.C., Mann D.M., Lee V.M.Y., and Trojanowski J.Q. Full-length amyloid-beta (1-42(43)) and amino-terminally modified and truncated amyloid-beta 42(43) deposit in diffuse plaques. Am. J. Pathol. 149 (1996) 1823-1830
70. Kakio A., Nishimoto S.I., Kozutsumi Y., and Matsuzaki K. Formation of a membrane-active form of amyloid beta-protein in raft-like model membranes. Biochem. Biophys. Res. Commun. 303 (2003) 514-518
71. Mori H., Takio K., Ogawara M., and Selkoe D.J. Mass spectrometry of purified amyloid beta protein in Alzheimer's disease. J. Biol. Chem. 267 (1992) 17082-17086
72. Jarrett J.T., Berger E.P., and Lansbury P.T. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 32 (1993) 4693-4697
73. Jarrett J.T., and Lansbury P.T. Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?. Cell 73 (1993) 1055-1058
74. Harper J.D., and Lansbury P.T. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu. Rev. Biochem. 66 (1997) 385-407
75. Pitschke M., Prior R., Haupt M., and Riesner D. Detection of single amyloid beta-protein aggregates in the cerebrospinal fluid of Alzheimer's patients by fluorescence correlation spectroscopy. Nat. Med. 4 (1998) 832-834
76. Koppaka V., Paul C., Murray I.V.J., and Axelsen P.H. Early synergy between Aβ42 and oxidatively damaged membranes in promoting amyloid fibril formation by Aβ40. J. Biol. Chem. 278 (2003) 36277-36284
77. Naiki H., Higuchi K., Hosokawa M., and Takeda T. Fluorometric-determination of amyloid fibrils in vitro using the fluorescent dye, Thioflavine-T. Anal. Biochem. 177 (1989) 244-249
78. Huang X.D., Cuajungco M.P., Atwood C.S., Hartshorn M.A., Tyndall J.D.A., Hanson G.R., Stokes K.C., Leopold M., Multhaup G., Goldstein L.E., Scarpa R.C., Saunders A.J., Lim J., Moir R.D., Glabe C., Bowden E.F., Masters C.L., Fairlie D.P., Tanzi R.E., and Bush A.I. Cu(II) potentiation of Alzheimer A beta neurotoxicity-Correlation with cell-free hydrogen peroxide production and metal reduction. J. Biol. Chem. 274 (1999) 37111-37116
79. Huang X.D., Atwood C.S., Hartshorn M.A., Multhaup G., Goldstein L.E., Scarpa R.C., Cuajungco M.P., Gray D.N., Lim J., Moir R.D., Tanzi R.E., and Bush A.I. The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 38 (1999) 7609-7616
80. Opazo C., Huang X.D., Cherny R.A., Moir R.D., Roher A.E., White A.R., Cappai R., Masters C.L., Tanzi R.E., Inestrosa N.C., and Bush A.I. Metalloenzyme-like activity of Alzheimer's disease beta-amyloid-Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H2O2. J. Biol. Chem. 277 (2002) 40302-40308
81. Nelson T.J., and Alkon D.L. Oxidation of cholesterol by amyloid precursor protein and beta-amyloid peptide. J. Biol. Chem. 280 (2005) 7377-7387
82. Barnham K.J., Haeffner F., Ciccotosto G.D., Curtain C.C., Tew D., Beyreuther K., Carrington D., Masters C.L., Cherny R.A., Cappai R., and Bush A.I. Tyrosine gated electron transfer is key to the toxic mechanism of Alzheimer's disease β-amyloid. FASEB J. 18 (2004) 1427-1429
83. Butterfield D.A., and Kanski J. Methionine residue 35 is critical for the oxidative stress and neurotoxic properties of Alzheimer's amyloid beta-peptide 1-42 [Review]. Peptides 23 (2002) 1299-1309
84. Butterfield D.A. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: Implications for neurodegeneration in Alzheimer's disease brain. A review. Free Radical Res. 36 (2002) 1307-1313
85. Butterfield D.A., and Bush A.I. Alzheimer's amyloid beta-peptide (1-42): involvement of methionine residue 35 in the oxidative stress and neurotoxicity properties of this peptide. Neurobiol. Aging 25 (2004) 563-568
86. Schneeweis L.A., Koppaka V., Lund-Katz S., Phillips M.C., and Axelsen P.H. Structural analysis of lipoprotein E particles. Biochemistry 44 (2005) 12525-12534
87. Bielicki J.K., and Oda M.N. Apolipoprotein A-I-Milano and apolipoprotein A-I-Paris exhibit an antioxidant activity distinct from that of wild-type apolipoprotein A-I. Biochemistry 41 (2002) 2089-2096
88. Hardy J., and Selkoe D.J. Medicine-The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297 (2002) 353-356
89. Lue L.F., Kuo Y.M., Roher A.E., Brachova L., Shen Y., Sue L., Beach T., Kurth J.H., Rydel R.E., and Rogers J. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am. J. Pathol. 155 (1999) 853-862
90. Mclean C.A., Cherny R.A., Fraser F.W., Fuller S.J., Smith M.J., Beyreuther K., Bush A.I., and Masters C.L. Soluble pool of A beta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann. Neurol. 46 (1999) 860-866
91. Wang J., Dickson D.W., Trojanowski J.Q., and Lee V.M.Y. The levels of soluble versus insoluble brain A beta distinguish Alzheimer's disease from normal and pathologic aging. Exp. Neurol. 158 (1999) 328-337
92. Naslund J., Haroutunian V., Mohs R., Davis K.L., Davies P., Greengard P., and Buxbaum J.D. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA-J. Am. Med. Assoc. 283 (2000) 1571-1577
93. Mandavilli A. The amyloid code. Nat. Med. 12 (2006) 747-751
94. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., Rowan M.J., and Selkoe D.J. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416 (2002) 535-539
95. Cleary J.P., Walsh D.M., Hofmeister J.J., Shankar G.M., Kuskowski M.A., Selkoe D.J., and Ashe K.H. Natural oligomers of the amyloid-protein specifically disrupt cognitive function. Nat. Neurosci. 8 (2005) 79-84
96. Lesne S., Koh M.T., Kotilinek L., Kayed R., Glabe C.G., Yang A., Gallagher M., and Ashe K.H. A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440 (2006) 352-357
97. Wimley W.C., Hristova K., Ladokhin A.S., Silvestro L., Axelsen P.H., and White S.H. Folding of beta-sheet membrane proteins: a hydrophobic hexapeptide model. J. Mol. Biol. 277 (1998) 1091-1110